Abstract
For an ever-increasing number of species, the completed genomic sequence is available, providing a means to identify all the genes encoded in a genome. The functional relationships between these genes must be defined in order to generate a cohesive understanding of the molecular events that direct metazoan development. The model organism C. elegans, with its completed genomic sequence, defined cell lineage and robust genetics, provides an excellent opportunity to reconstruct the genetic relationships that underlie the development of a relatively simple animal. The change in expression of every predicted gene in the genome can be quantified under defined experimental conditions using DNA microarrays, thus providing a ”molecular signature“ of particular developmental processes. Because DNA microarray analysis does not rely upon detection of a gross morphological phenotype, genes whose function escapes identification in mutation screens can now be associated with different developmental processes. Together, C. elegans and DNA microarrays are a powerful combination with which to attack complex problems in developmental biology and work toward a more complete understanding of the underlying genetic networks governing development.
Keywords: Gene expression profiling, Functional genomics, clustering, microarrays
Current Genomics
Title: Defining Development Through Gene Expression Profiling
Volume: 3 Issue: 2
Author(s): Valerie Reinke
Affiliation:
Keywords: Gene expression profiling, Functional genomics, clustering, microarrays
Abstract: For an ever-increasing number of species, the completed genomic sequence is available, providing a means to identify all the genes encoded in a genome. The functional relationships between these genes must be defined in order to generate a cohesive understanding of the molecular events that direct metazoan development. The model organism C. elegans, with its completed genomic sequence, defined cell lineage and robust genetics, provides an excellent opportunity to reconstruct the genetic relationships that underlie the development of a relatively simple animal. The change in expression of every predicted gene in the genome can be quantified under defined experimental conditions using DNA microarrays, thus providing a ”molecular signature“ of particular developmental processes. Because DNA microarray analysis does not rely upon detection of a gross morphological phenotype, genes whose function escapes identification in mutation screens can now be associated with different developmental processes. Together, C. elegans and DNA microarrays are a powerful combination with which to attack complex problems in developmental biology and work toward a more complete understanding of the underlying genetic networks governing development.
Export Options
About this article
Cite this article as:
Reinke Valerie, Defining Development Through Gene Expression Profiling, Current Genomics 2002; 3 (2) . https://dx.doi.org/10.2174/1389202024605215
DOI https://dx.doi.org/10.2174/1389202024605215 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
SRC: Regulation, Role in Human Carcinogenesis and Pharmacological Inhibitors
Current Pharmaceutical Design A Novel Mechanism for Metal-independent Hydroxyl Radical Production by Hydrogen Peroxide and Halogenated Quinones
Mini-Reviews in Organic Chemistry Recent Patents Relating To HCV Molecules Like Putative Targets For Therapeutic Intervention
Recent Patents on DNA & Gene Sequences Notch Signaling Proteins: Legitimate Targets for Cancer Therapy
Current Protein & Peptide Science Fungal Bioactive Compounds in Pharmaceutical Research and Development
Current Bioactive Compounds The Integrative Network of Gene Expression, MicroRNA, Methylation and Copy Number Variation in Colon and Rectal Cancer
Current Bioinformatics Diagnostic and Prognostic Markers in Differentiated Thyroid Cancer
Current Genomics Viral Product Trafficking to Mitochondria, Mechanisms and Roles in Pathogenesis
Infectious Disorders - Drug Targets Programmed Cell Death after Intracerebral Hemorrhage
Current Neuropharmacology A New Era of Pulmonary Delivery of Nano-antimicrobial Therapeutics to Treat Chronic Pulmonary Infections
Current Pharmaceutical Design Perspective of MiRNAs in Clinical Glioblastoma Research
Current Signal Transduction Therapy Evaluation of Echocardiographic Abnormalities in HIV Positive Patients Treated with Antiretroviral Medications
Infectious Disorders - Drug Targets Replicative Oncolytic Herpes Simplex Viruses in Combination Cancer Therapies
Current Gene Therapy Evolving Drug Delivery Strategies to Overcome the Blood Brain Barrier
Current Pharmaceutical Design Exploration of Structure-Based on Imidazole Core as Antibacterial Agents
Current Topics in Medicinal Chemistry Stem Cells and Bioactive Scaffolds as a Treatment for Traumatic Brain Injury
Current Stem Cell Research & Therapy Talazoparib Loaded Solid Lipid Nanoparticles: Preparation, Characterization and Evaluation of the Therapeutic Efficacy In vitro
Current Drug Delivery Inhibition of Angiogenesis as a Treatment Strategy for Neuroblastoma
Current Cancer Therapy Reviews Tocilizumab Labeling with 99mTechnetium via HYNIC as a Molecular Diagnostic Agent for Multiple Myeloma
Anti-Cancer Agents in Medicinal Chemistry Targeting Endothelial Progenitor Cells in Cancer as a Novel Biomarker and Anti-Angiogenic Therapy
Current Stem Cell Research & Therapy